# Sanofi Winthrop Industrie - Inspection Records

Source: https://www.keypedia.com/companies/sanofi-winthrop-industrie/f7668868-7954-441c-b8bf-ab135e8645c2

> Inspection records and compliance data for Sanofi Winthrop Industrie in Lyon, None. Access full analysis and detailed observations.

---

## Details

- Name: Sanofi Winthrop Industrie
- FEI Number: 3009194033
- City: Lyon
- State: None
- Country Name: France
- Address Line 1: 23 Boulevard Chambaud De La Bruyere
- Zip Code: None

## Related Documents

- [483 - Sanofi Winthrop Industrie - Unknown Date](https://www.keypedia.com/records/483/sanofi-winthrop-industrie/8dbf51b4-593d-49e9-9f9f-d9b7e01f7289) — source: FDA, date: Invalid Date
- [FDA Inspection 1227792 - Sanofi Winthrop Industrie - 2024-01-26](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/3de20bb5-b52b-4167-be9a-6f65dcbd7be9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 26, 2024
- [483 - Sanofi Winthrop Industrie - 2023-11-17](https://www.keypedia.com/records/483/sanofi-winthrop-industrie/7257f075-b1f8-4445-ba17-1f7747e566b9) — source: FDA, date: November 17, 2023
- [FDA Inspection 1223859 - Sanofi Winthrop Industrie - 2023-11-17](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/b6dae7b6-1de5-4a55-90f3-3f14c11e72eb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 17, 2023
- [FDA Inspection 1120933 - Sanofi Winthrop Industrie - 2020-02-18](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/72018efa-3a51-4b8f-ad0b-598000e372f2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 18, 2020
- [FDA Inspection 1059004 - Sanofi Winthrop Industrie - 2018-07-13](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/16482ad2-60b3-4aaf-9744-d4283b47bbaa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 13, 2018
- [FDA Inspection 994790 - Sanofi Winthrop Industrie - 2016-07-28](https://www.keypedia.com/records/fda_inspections/sanofi-winthrop-industrie/4ddbafe5-fa86-46f9-b70c-1c89b92c1ab8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 28, 2016

## Related Companies

- [Immunex Rhode Island Corporation](https://www.keypedia.com/companies/immunex-rhode-island-corporation/c70ebfcc-0c4d-4294-845a-24f1af8f30e9)
- [Sucampo Pharma, LLC](https://www.keypedia.com/companies/sucampo-pharma-llc/5a5bffc7-663f-47ab-8ccf-2078e2f49f60)
- [Abbvie Biotechnology Ltd.](https://www.keypedia.com/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41)
- [Taixing SynTheAll Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/taixing-syntheall-pharmaceutical-co-ltd/7acaa1ac-b9fc-4fed-8ac5-a6b413bdf3e1)
- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/b597b205-d758-426b-bc64-09970b3a1b83)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)
- [Hovione LLC](https://www.keypedia.com/companies/hovione-llc/06b4417a-5377-4e73-8076-71d3066fa8f0)
- [BSP Pharmaceuticals SpA](https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)

## Related Officers

- [Deborah A. Tolomeo, CSO](https://www.keypedia.com/people/deborah-a-tolomeo-cso/f92e206f-2cde-49ef-8f56-27f3bb93c30c)
- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [Investigator](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)
- [Lewis K. Antwi](https://www.keypedia.com/people/lewis-k-antwi/8ab4f1c7-8b5b-4556-98a4-6edc3bc49470)